Table 6.
Gefitinib 250 mg/day | Reduced dose | Total | |
---|---|---|---|
RECIST | |||
CR | 1 | 1 | 2 |
PR | 6 | 5 | 11 |
SD | 2 | 2 | 4 |
PD | 6 | 1 | 7 |
CR + PR (%) | 7 (46.7) | 6 (66.7) | 13 (54.2) |
Abbreviations: RECIST, Response Evaluation Criteria in Solid Tumors; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.